FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications

Retrieved on: 2021-04-13 19:48:06

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications. View article details on hiswai:

Excerpt

Basel, 13 April 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved the ...

Article found on: www.roche.com